rs138055271

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003126.4(SPTA1):ā€‹c.6437A>Gā€‹(p.Gln2146Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,614,130 control chromosomes in the GnomAD database, including 103 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0085 ( 5 hom., cov: 32)
Exomes š‘“: 0.011 ( 98 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

1
6
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 7.53
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009320557).
BP6
Variant 1-158619315-T-C is Benign according to our data. Variant chr1-158619315-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 258953.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=3, Likely_benign=2, Benign=3}. Variant chr1-158619315-T-C is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPTA1NM_003126.4 linkuse as main transcriptc.6437A>G p.Gln2146Arg missense_variant 45/52 ENST00000643759.2
SPTA1XM_011509916.3 linkuse as main transcriptc.6437A>G p.Gln2146Arg missense_variant 46/53
SPTA1XM_011509917.4 linkuse as main transcriptc.6437A>G p.Gln2146Arg missense_variant 45/51
SPTA1XM_047428883.1 linkuse as main transcriptc.6116A>G p.Gln2039Arg missense_variant 45/52

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SPTA1ENST00000643759.2 linkuse as main transcriptc.6437A>G p.Gln2146Arg missense_variant 45/52 NM_003126.4 P1P02549-1
SPTA1ENST00000484520.1 linkuse as main transcriptn.640A>G non_coding_transcript_exon_variant 2/23

Frequencies

GnomAD3 genomes
AF:
0.00847
AC:
1290
AN:
152220
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00903
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0133
Gnomad OTH
AF:
0.0129
GnomAD3 exomes
AF:
0.00841
AC:
2099
AN:
249572
Hom.:
11
AF XY:
0.00824
AC XY:
1116
AN XY:
135396
show subpopulations
Gnomad AFR exome
AF:
0.00278
Gnomad AMR exome
AF:
0.00649
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00196
Gnomad FIN exome
AF:
0.00696
Gnomad NFE exome
AF:
0.0132
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.0111
AC:
16283
AN:
1461792
Hom.:
98
Cov.:
31
AF XY:
0.0108
AC XY:
7847
AN XY:
727198
show subpopulations
Gnomad4 AFR exome
AF:
0.00206
Gnomad4 AMR exome
AF:
0.00657
Gnomad4 ASJ exome
AF:
0.00444
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00235
Gnomad4 FIN exome
AF:
0.00867
Gnomad4 NFE exome
AF:
0.0129
Gnomad4 OTH exome
AF:
0.0110
GnomAD4 genome
AF:
0.00846
AC:
1289
AN:
152338
Hom.:
5
Cov.:
32
AF XY:
0.00805
AC XY:
600
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.00267
Gnomad4 AMR
AF:
0.00895
Gnomad4 ASJ
AF:
0.00375
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00186
Gnomad4 FIN
AF:
0.00631
Gnomad4 NFE
AF:
0.0133
Gnomad4 OTH
AF:
0.0128
Alfa
AF:
0.0121
Hom.:
18
Bravo
AF:
0.00853
TwinsUK
AF:
0.0143
AC:
53
ALSPAC
AF:
0.0140
AC:
54
ESP6500AA
AF:
0.00276
AC:
11
ESP6500EA
AF:
0.0115
AC:
96
ExAC
AF:
0.00851
AC:
1029
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0133
EpiControl
AF:
0.0158

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicNov 09, 2021- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 13, 2023- -
Benign, criteria provided, single submitterclinical testingInvitaeDec 28, 2023- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2023SPTA1: BP4, BS1, BS2 -
Hereditary spherocytosis type 3 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Pyropoikilocytosis, hereditary Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesApr 11, 2016- -
Elliptocytosis 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T;T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
.;D
MetaRNN
Benign
0.0093
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;M
MutationTaster
Benign
0.98
D;D
PrimateAI
Benign
0.41
T
REVEL
Benign
0.17
Sift4G
Uncertain
0.042
D;.
Polyphen
0.45
P;P
Vest4
0.27
MVP
0.74
MPC
0.096
ClinPred
0.016
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.22
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138055271; hg19: chr1-158589105; API